The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson’s Disease-Reference-Cited by-同舟云学术

The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson’s Disease

Author:

Zhang Lingyu¹,Zhang Liping¹,Li Yanwei²,Li Lin¹,Melchiorsen Josefine Ulrikke³,Rosenkilde Mette³,Hölscher Christian⁴⁵

Affiliation:

1. Key Laboratory of Cellular Physiology, Shanxi Medical University, Taiyuan, Shanxi, PR China

2. Department of Human Anatomy, Shaoyang Medical College, Shaoyang, Hunan, PR China

3. Department of Biomedical Science, University of Copenhagen, Copenhagen, Denmark

4. Department of Second Hospital Neurology, Shanxi Medical University, Taiyuan, Shanxi, PR China

5. Research and Experimental Center, Henan University of Chinese Medicine, Zhengzhou, Henan province, PR China

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Clinical Neurology

Reference73 articles.

3. Parkinson disease;Poewe;Nat Rev Dis Primers,2017

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献